Revenue: The sum of all revenue fields included for a company's operating activities.
Taysha Gene Therapies, Inc. (TSHA) had Revenue of $2.30M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$2.30M |
$-21.53M |
|
-- |
|
$2.30M |
|
$23.72M |
|
$-21.42M |
|
$-0.11M |
|
$-21.53M |
|
$-21.53M |
|
$-21.53M |
|
$-21.53M |
|
$-21.53M |
|
$-21.53M |
|
$-21.42M |
|
$-21.14M |
|
269.31M |
|
269.31M |
|
$-0.08 |
|
$-0.08 |
|
| Balance Sheet Financials | |
$120.71M |
|
$7.24M |
|
$17.65M |
|
$138.36M |
|
$22.56M |
|
$42.45M |
|
$60.75M |
|
$83.30M |
|
$55.06M |
|
$55.06M |
|
$55.06M |
|
205.06M |
|
| Cash Flow Statement Financials | |
$-22.02M |
|
$-0.37M |
|
$-0.05M |
|
$141.64M |
|
$119.19M |
|
$-22.44M |
|
$3.29M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.35 |
|
-- |
|
-- |
|
0.44 |
|
0.77 |
|
100.00% |
|
-930.54% |
|
-930.54% |
|
-- |
|
-935.23% |
|
-935.23% |
|
$-22.40M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
-- |
|
-- |
|
-39.10% |
|
-39.10% |
|
-15.56% |
|
-22.08% |
|
$0.27 |
|
$-0.08 |
|
$-0.08 |
|